Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 6.55% and Operating profit at -18.96% over the last 5 years
2
The company declared very negative results in Mar'25 after negative results in Dec'24
3
With ROE of 4.34%, it has a very expensive valuation with a 2.80 Price to Book Value
4
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.36%
0%
-8.36%
6 Months
-13.26%
0%
-13.26%
1 Year
-0.33%
0%
-0.33%
2 Years
6.57%
0%
6.57%
3 Years
-0.16%
0%
-0.16%
4 Years
30.72%
0%
30.72%
5 Years
33.88%
0%
33.88%
Shanghai No. 1 Pharmacy Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.55%
EBIT Growth (5y)
-18.96%
EBIT to Interest (avg)
5.25
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
1.57
Tax Ratio
24.25%
Dividend Payout Ratio
30.10%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.63%
ROE (avg)
10.06%
Valuation key factors
Factor
Value
P/E Ratio
65
Industry P/E
Price to Book Value
2.80
EV to EBIT
167.61
EV to EBITDA
30.12
EV to Capital Employed
3.57
EV to Sales
1.37
PEG Ratio
NA
Dividend Yield
1.59%
ROCE (Latest)
2.13%
ROE (Latest)
4.34%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
484.60
504.00
-3.85%
Operating Profit (PBDIT) excl Other Income
-1.60
22.00
-107.27%
Interest
0.80
1.40
-42.86%
Exceptional Items
0.00
0.00
Consolidate Net Profit
23.70
4.80
393.75%
Operating Profit Margin (Excl OI)
-3.20%
7.90%
-1.11%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is -3.85% vs 9.07% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 393.75% vs -86.70% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,126.90
1,911.80
11.25%
Operating Profit (PBDIT) excl Other Income
71.30
88.20
-19.16%
Interest
5.10
6.80
-25.00%
Exceptional Items
-1.30
-4.60
71.74%
Consolidate Net Profit
58.50
163.60
-64.24%
Operating Profit Margin (Excl OI)
-2.90%
8.40%
-1.13%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 11.25% vs 5.29% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -64.24% vs 83.20% in Dec 2024
About Shanghai No. 1 Pharmacy Co. Ltd. 
Shanghai No. 1 Pharmacy Co. Ltd.
Retailing
No Details Available.
Company Coordinates 
No Company Details Available






